Choose a Drug ! Aciphex Acomplia Actos Acyclovir Allegra Alli Diet Drug Altace Ambien Amoxicillin Atenolol Ativan Augmentin Avandia Avapro Baclofen Bactrim Biaxin Celebrex Celexa Cephalexin Champix Cialis Cipro Claritin D Clomid Coreg Depakote Diflucan Dilantin Diovan Doxycycline Effexor XR Elavil Estradiol Flomax Flonase Fluoxetine Folic Acid Fosamax Glucophage Hydroxyzine Ibuprofen Imitrex Keflex Lamisil Lasix Levaquin Levitra Lexapro Lipitor Mobic Naproxen Neurontin Nexium Norvasc Omeprazole Paxil Plavix Premarin Prevacid Promethazine Propecia Proscar Protonix Reductil Reglan Remeron Risperdal Singulair Sonata Synthroid Tamiflu Topamax Trazodone Ultra "C" tabs Ultra "L" tabs Ultra "V" tabs Ultram Viagra Wellbutrin Xenical Zithromax Zocor Zoloft Zyban Zyprexa Zyrtec

September 2007 August 2007 July 2007 June 2007 May 2007 April 2007 March 2007 February 2007 January 2007 December 2006 November 2006 October 2006 September 2006 August 2006 July 2006 June 2006 May 2006 April 2006 March 2006 February 2006

Opt-in for Free Newsletter, special discount offers, drugs information & latest pharmacy news.

US panel urges heart risk warning on ADHD drugs

GAITHERSBURG, Maryland (Reuters) - Prescription drugs to treat attention deficit disorder should come with strong 'black-box' warnings that they may increase the risk of heart problems in some patients, a U.S. advisory panel said on Thursday.

The Food and Drug Administration committee voted 8-7 in favor of the warning, with one abstention. Fifteen members also voted to recommend the drugs, which include Novartis AG's Ritalin and Shire Pharmaceuticals Group Plc's Adderall, be dispensed with a patient-friendly guide that explained possible side effects.

Source: http://today.reuters.co.uk/news/newsArticle.aspx?type=healthNews&storyID=2006-02-09T205054Z_01_WBT004761_RTRIDST_0_HEALTH-ATTENTION-DC.XML